Before the start of the Management of Myelomeningocele Study (MOMS) in 2003, an initial group of 58 patients at CHOP underwent in utero repair of their myelomeningocele between 21 and 25 weeks' gestation. Urologic results after fMMC repair are discussed here.

The CFDT Center at CHOP recently reviewed outcomes for fetal MMC repair since the MOMS results were reported, from referral and evaluation through surgery, delivery and neonatal discharge.

The Children’s Hospital of Philadelphia is the first children’s hospital to be selected as a finalist for the 2014 Foster G. McGaw Prize.

The Children’s Hospital of Philadelphia unveiled a portrait of Ruth M. and Tristram C. Colket Jr. in October to honor their more than 40 years of extraordinary dedication to CHOP.

Researchers at The Children's Hospital of Philadelphia improved motor function and brain abnormalities in animals with a form of Huntington’s disease, a severe neurological disorder.

Stevens-Johnson syndrome (SJS) is a lifethreatening cutaneous immune-mediated reaction involving blistering and desquamation of the skin and mucous membranes.

Congenital anomalies such as spina bifida can result in a wide range of urologic disorders and necessitate comprehensive, long-term management.

Read the findings of Dr. Rychik's study that investigated the cardiovascular consequences of lower urinary tract obstructions LUTO in the fetus.

Bladder exstrophy is a severe developmental disorder in which the bladder protrudes inferior to umbilical cord insertion and separation of the pubic bones results in divergence of the rectus muscles.

Proper diagnosis of LUTO, treatment and follow-up require an experienced, multidisciplinary team that understands not only the pathogenesis of this condition but also the best options for treatment.